Related Experiment Video
Updated: May 27, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
[Scalp cooling for chemotherapy-induced alopecia]
Marion M C Komen1, Carolien H Smorenburg, Corina J G van den Hurk
1Medisch Centrum Alkmaar, afd. Oncologie, Alkmaar, the Netherlands. manon.komen@mca.nl
Scalp cooling can prevent chemotherapy-induced alopecia, a distressing side effect. This method is generally well-tolerated, with few reported side effects, and does not increase the risk of scalp metastases.
Area of Science:
- Oncology
- Dermatology
Context:
- Alopecia is a common and distressing side effect of cytostatic (chemotherapy) therapy.
- Scalp cooling is utilized in 59 Dutch hospitals to mitigate chemotherapy-induced alopecia.
- Factors influencing scalp cooling efficacy include chemotherapy type, dose, and duration.
Purpose:
- To establish a national guideline for managing chemotherapy-induced alopecia.
- To standardize the use of scalp cooling in medical oncology.
Summary:
- Scalp cooling is a well-tolerated intervention for preventing hair loss during chemotherapy.
- Reported side effects are generally mild, including headache and coldness.
- No increased risk of scalp metastases has been observed with scalp cooling.
Impact:
- A national guideline will improve consistency in alopecia prevention strategies.
- Enhanced patient quality of life by reducing a significant treatment side effect.
- Provides evidence-based recommendations for oncologists and healthcare providers.
Related Concept Videos
Decreased Body Temperature
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

